CytomX Therapeutics
Price & Volume
Stats
See more52W Range | $0.48-$8.21 |
Market Cap | $929.5M |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $76.2M |
Revenue Growth (YoY) | -98.3% |
Gross Profit (12 Mos) | $76.2M |
Diluted EPS | -$0.15 |
News
See moreYahoo Finance • 10 days ago
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
Yahoo Finance • 23 days ago
CytomX Unveils $250 Mln Offering Of Shares And Warrants To Advance Varseta-M And Other Pipeline
Yahoo Finance • 24 days ago
Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data
Yahoo Finance • 24 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
About
CEO | Dr. Sean A. McCarthy DPHIL |
Address | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |
